Pays: Royaume-Uni
Langue: anglais
Source: MHRA (Medicines & Healthcare Products Regulatory Agency)
Sotalol hydrochloride
Tillomed Laboratories Ltd
C07AA07
Sotalol hydrochloride
40mg
Oral tablet
Oral
No Controlled Drug Status
Valid as a prescribable product
BNF: 02040000; GTIN: 5024655000494
Page 1 of 5 PACKAGE LEAFLET: INFORMATION FOR THE PATIENT SOTALOL HYDROCHLORIDE 40MG AND 80MG TABLETS READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START TAKING THIS MEDICINE BECAUSE IT CONTAINS IMPORTANT INFORMATION FOR YOU. • Keep this leaflet. You may need to read it again. • If you have any further questions, ask your doctor or pharmacist. • This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours. • If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. See section 4. WHAT IS IN THIS LEAFLET: 1. What Sotalol is and what it is used for 2. What you need to know before you take Sotalol 3. How to take Sotalol 4. Possible side effects 5. How to store Sotalol 6. Contents of the pack and other information 1 WHAT SOTALOL IS AND WHAT IT IS USED FOR Sotalol Hydrochloride belongs to a group of medicines called Beta−Blockers and works by slowing the electrical impulses in the heart muscle. This helps to regulate and restore disturbances in the heart rhythm. Sotalol also blocks beta receptors that are found in the heart. This causes the heart to beat more slowly and with less force. Sotalol Hydrochloride (referred to as Sotalol throughout this leaflet) is used: • To treat fast and irregular heartbeat (arrhythmias) some of which may be life-threatening. • As prophylaxis, to prevent the occurrence of new arrhythmias. 2 WHAT YOU NEED TO KNOW BEFORE YOU TAKE DO NOT TAKE SOTALOL: • IF YOU HAVE A HISTORY OF BREATHING DIFFICULTIES, WHEEZING OR ASTHMA • If you are allergic to Sotalol, other Beta-Blockers or any of the other ingredients of this medicine (listed in Section 6) • If you have an irregular heartbeat caused by sick sinus syndrome, long QT syndromes or Torsades de Pointes • If you suffer from a condition where the heart beats irregularly or much more slowly than normal (2nd or 3rd degree heart block) UNLESS YOU HAVE PACEMAKER • If y Lire le document complet
OBJECT 1 SOTALOL 40MG TABLETS Summary of Product Characteristics Updated 28-Aug-2020 | Tillomed Laboratories Ltd • 1. Name of the medicinal product • 2. Qualitative and quantitative composition • 3. Pharmaceutical form • 4. Clinical particulars • 4.1 Therapeutic indications • 4.2 Posology and method of administration • 4.3 Contraindications • 4.4 Special warnings and precautions for use • 4.5 Interaction with other medicinal products and other forms of interaction • 4.6 Pregnancy and lactation • 4.7 Effects on ability to drive and use machines • 4.8 Undesirable effects • 4.9 Overdose • 5. Pharmacological properties • 5.1 Pharmacodynamic properties • 5.2 Pharmacokinetic properties • 5.3 Preclinical safety data • 6. Pharmaceutical particulars • 6.1 List of excipients • 6.2 Incompatibilities • 6.3 Shelf life • 6.4 Special precautions for storage • 6.5 Nature and contents of container • 6.6 Special precautions for disposal and other handling • 7. Marketing authorisation holder • 8. Marketing authorisation number(s) • 9. Date of first authorisation/renewal of the authorisation • 10. Date of revision of the text 1. Name of the medicinal product Sotalol Hydrochloride 40mg Tablets 2. Qualitative and quantitative composition Each tablet contains 40mg sotalol hydrochloride. Excipient with known effect: Each tablet contains 13.37mg of lactose (as lactose monohydrate). For the full list of excipients, see section 6.1. 3. Pharmaceutical form Tablets for oral administration. White, round, biconvex tablets of diameter 5.4mm–5.6mm and height of 2.8mm-3.0mm, marked “SOT” on one side. 4. Clinical particulars 4.1 Therapeutic indications Sotalol hydrochloride tablets are indicated for: Ventricular arrhythmias: • treatment of life-threatening ventricular tachyarrhythmias; • treatment of symptomatic non-sustained ventricular tachyarrhythmias. Supraventricular arrythmias: • prophylaxis of paroxysmal atrial tachycardia, paroxysmal atrial fibrillation, paroxysmal A-V nod Lire le document complet